Press Releases

Interventional Pulmonology Market is Anticipated to Grow US$ 8 Bn By 2030

Share This Article

The Interventional Pulmonology market is projected to grow from USD 3 billion in 2020 to reach USD 8 billion by 2030; it is expected to grow at a Compound Annual Growth Rate (CAGR) of 9.1% from 2021 to 2030.

Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/38741

Interventional pulmonology uses endoscopy and other tools to diagnose and treat conditions in the lungs and chest by using minimally invasive techniques. Rise in prevalence of respiratory disorders, increase in geriatric population, and surge in incidence of diseases that require endoscopic ultrasound procedures are the major factors anticipated to drive the global interventional pulmonology market during the forecast period.

Targeted Therapies, Collaboration among IP Workforce Help Improve Medical Outcomes

Lung cancer diagnosis, staging, and management of the pulmonary nodule contribute to a significant portion of an IP’s work. Since lung cancer screening programs are surging in many parts of the world, it is highly possible that the workload of IPs will increase in the future. However, targeting the peripheral pulmonary nodule as well as accurate mediastinal staging is a daily challenge for the IP workforce. In order to tide over these challenges, stakeholders are mainly focusing on personalized medicine, targeted therapies, and collaboration among IP, medical oncology, and pathology to ensure patient quality of life (QOL).

Robotic Bronchoscopy Platforms Show Potential in Accurate Diagnosis of Lung Cancer

Robotic bronchoscopy is emerging as a game changer in the interventional pulmonology market. This explains why the market is estimated to register a striking CAGR of 9% during the forecast period. Companies are expected to collaborate with researchers to innovate in novel robotic bronchoscopy platforms that allow pulmonologists to clearly see and reach lung nodules without invasive surgery.

Rapid and accurate diagnosis of lung cancer have become the need of the hour in the interventional pulmonology market. This has triggered developments in robotic bronchoscopy platforms, which consist of a hand-held controller used to direct a small, flexible endoscope into the lung using a computer-assisted navigation. In this platform, the camera allows the physician to view a magnified image of the lung, which helps to deliver rapid and accurate diagnosis of lung cancer.

Overview

  • This report analyzes the current scenario and future prospects of the global interventional pulmonology market. Significant applications of interventional pulmonology devices are projected to boost the growth of the global interventional pulmonology market from 2021 to 2030.
  • The report includes an elaborate executive summary, which provides a snapshot of various segments of the global interventional pulmonology market. It also provides information and data analysis of the global interventional pulmonology market with regards to segments based on product type, indication, end user, and region.
  • The overview section of the report provides a detailed qualitative analysis of drivers, restraints, and opportunities that impact the global interventional pulmonology market
  • The report includes company profiles, which provide information about their business, product portfolios, and competitive landscape in the global interventional pulmonology market
  • The report on the global interventional pulmonology market offers market attractiveness analysis of regions and segments
  • The last section of the report comprises quantitative and qualitative analyses on market share/position of key players operating in the global interventional pulmonology market. It analyzes key competitive strategies adopted by major industry players, thereby presenting a thorough understanding of the competitive scenario in the global interventional pulmonology market.

Report Highlights

In terms of product type, the global interventional pulmonology market has been classified into bronchoscopes, electromagnetic navigation bronchoscopy systems, pleuroscopes, respiratory endotherapy devices, airway stents, pleural catheters, endobronchial valves, and bronchial thermoplasty systems. The respiratory endotherapy devices segment dominated the global interventional pulmonology market in 2020 and the trend is projected to continue during the forecast period. Respiratory endotherapy devices are used for bronchoscopic or endoscopic diagnostics and surgery. Devices used in endotherapy include biopsy forceps, cytology brushes, aspiration needles, electrosurgery snares, and foreign body removal tools, guide sheaths, and other similar devices used for respiratory endotherapy procedures.

Based on indication, the global interventional pulmonology market has been categorized into asthma, COPD, lung cancer, tracheal & bronchial stenosis, and others. The asthma segment held major share of the global interventional pulmonology market in 2020. Asthma affects all age groups, but often starts in the childhood. It is a disease characterized by recurrent attacks of breathlessness and wheezing, which vary in severity and frequency from person to person. In an individual, it could occur from hour to hour and day to day.

In terms of end user, the global interventional pulmonology market has been divided into hospitals, ambulatory surgical centers, diagnostic centers, specialty clinics, and others. The hospitals segment held a major share of the global interventional pulmonology market in 2020.

In terms of region, the global interventional pulmonology market has been segmented into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa.

North America is anticipated to account for a leading share of the global interventional pulmonology market during the forecast period. The interventional pulmonology market in Asia Pacific is expected to grow at a rapid pace in the near future. India and China are likely to be lucrative markets for interventional pulmonology during the forecast period.

Key Players

Key players operating in the global interventional pulmonology market are Argon Medical, Body Vision Medical Ltd., Boston Scientific Corporation, C. R. Bard, Inc. (Becton, Dickinson and Company), CONMED Corporation, Cook, ENDO-FLEX GmbH, Fujifilm Corporation, KARL STORZ SE & Co. KG, Medtronic, Olympus Corporation, Pennine Healthcare, PENTAX Medical, Pulmonx Corporation, Richard Wolf GmbH, Rocket Medical plc., TAEWOONG, and Vygon, among others. These companies engage in research & development to develop novel products in order to expand product offerings and customer base.

Report Scope of the Interventional Pulmonology Market

Report Coverage Details
Market Size US$ 8 billion by 2030
Growth Rate CAGR of 9.1% From 2021 to 2030
Base Year 2021
Forecast Period 2021 to 2030
Largest Market North America
Fastest Growing Market Asia Pacific
Companies Mentioned Argon Medical, Body Vision Medical Ltd., Boston Scientific Corporation, C. R. Bard, Inc. (Becton, Dickinson and Company), CONMED Corporation, Cook, ENDO-FLEX GmbH, Fujifilm Corporation, KARL STORZ SE & Co. KG, Medtronic, Olympus Corporation, Pennine Healthcare, PENTAX Medical, Pulmonx Corporation, Richard Wolf GmbH, Rocket Medical plc., TAEWOONG, and Vygon

Global Interventional Pulmonology Market: Segmentation

By Product Type

    • Bronchoscopes
      • Flexible Bronchoscopes
      • Endobronchial Ultrasound Bronchoscopes (EBUS)
    • Electromagnetic Navigation Bronchoscopy Systems
    • Pleuroscopes
    • Respiratory Endotherapy Devices
      • Aspiration Needles
      • Biopsy Forceps
      • Biopsy Brush
      • Biopsy Needles
      • Catheter
      • Pulmonary Catheter
      • Balloon Dilatation Catheter
      • Others (airway retrieval basket, airway suction catheter, etc.)
    • Airway Stents
    • Pleural Catheters
    • Endobronchial Valves
    • Bronchial Thermoplasty Systems

By Indication

    • Asthma
    • COPD
    • Lung Cancer
    • Tracheal & Bronchial Stenosis
    • Others

By End User

    • Hospitals
    • Ambulatory Surgical Centers
    • Diagnostic Centers
    • Specialty Clinics
    • Others

By Region

    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Australia & New Zealand
      • Rest of Asia Pacific
    • Latin America
      • Brazil
      • Mexico
      • Rest of Latin America
    • Middle East & Africa
      • GCC Countries
      • South Africa
      • Rest of Middle East & Africa

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38741

Research Objectives and Research Approach

The comprehensive report on the global interventional pulmonology market begins with an overview of the market, followed by the scope and objectives of this study. Following this, the report provides detailed explanation of the objectives behind the study and healthcare compliances laid down by accredited agencies in the purview of research in the global interventional pulmonology market. It is followed by market introduction, market dynamics, and an overview of the global interventional pulmonology market, which includes VRR analysis of market drivers, restraints, and opportunities affecting the growth of the global interventional pulmonology market. Furthermore, Y-o-Y analysis with elaborate insights has been provided to understand the Y-o-Y trends of the global interventional pulmonology market.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section further divided into smaller ones. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global interventional pulmonology market in terms of product type, indication, end user, and region. Key segments under each criteria have been studied at length, and the market share for each of these at the end of 2030 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investments in the interventional pulmonology market.

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38741

Contact Us:

Vision Research Reports

Call: +1 9197 992 333

Email: sales@visionresearchreports.com

Related Articles

Back to top button